ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 128,90
0,38%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Actualités

CRMD

CorMedix (CRMD)

CorMedix Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:CRMD
DateHeureSourceTitreSymboleSociété
28/06/202323h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:CRMDCorMedix Inc
21/06/202314h43Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CRMDCorMedix Inc
19/05/202322h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:CRMDCorMedix Inc
19/05/202300h26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:CRMDCorMedix Inc
17/04/202322h07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CRMDCorMedix Inc
30/03/202314h32Edgar (US Regulatory)Annual Report (10-k)AMEX:CRMDCorMedix Inc
14/02/202316h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:CRMDCorMedix Inc
10/11/202214h17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CRMDCorMedix Inc
08/07/202223h01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CRMDCorMedix Inc
29/10/202122h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:CRMDCorMedix Inc
12/08/202122h29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:CRMDCorMedix Inc
11/02/202123h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:CRMDCorMedix Inc
02/02/202115h16Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:CRMDCorMedix Inc
02/02/202114h31Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:CRMDCorMedix Inc
01/02/202122h01Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:CRMDCorMedix Inc
21/01/202114h30GlobeNewswire Inc.CorMedix Inc. to Begin Trading on the Nasdaq Stock ExchangeAMEX:CRMDCorMedix Inc
27/11/202012h04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:CRMDCorMedix Inc
18/11/202014h30GlobeNewswire Inc.CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not NeededAMEX:CRMDCorMedix Inc
05/11/202022h05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
02/11/202014h30GlobeNewswire Inc.CorMedix Appoints Greg Duncan to its Board of DirectorsAMEX:CRMDCorMedix Inc
08/10/202015h00GlobeNewswire Inc.CorMedix to Participate in BIO Investor Forum DigitalAMEX:CRMDCorMedix Inc
17/09/202014h30GlobeNewswire Inc.CorMedix Appoints Paulo Costa to its Board of DirectorsAMEX:CRMDCorMedix Inc
09/09/202014h30GlobeNewswire Inc.CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceAMEX:CRMDCorMedix Inc
31/08/202013h47GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for DefencathAMEX:CRMDCorMedix Inc
10/08/202022h05GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
10/08/202014h31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:CRMDCorMedix Inc
28/07/202015h21GlobeNewswire Inc.CorMedix Announces Pricing of $20M Public Offering of Common StockAMEX:CRMDCorMedix Inc
27/07/202022h05GlobeNewswire Inc.CorMedix Announces Proposed Public Offering of Common StockAMEX:CRMDCorMedix Inc
08/07/202014h30GlobeNewswire Inc.CorMedix Inc. Reports Submission of Defencath™ New Drug ApplicationAMEX:CRMDCorMedix Inc
11/05/202022h10GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business UpdateAMEX:CRMDCorMedix Inc
 Showing the most relevant articles for your search:AMEX:CRMD

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
EU
ORA
Orange
EU
VK
Vallourec
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
EU
LR
Legrand
EU
RI
Pernod Ricard
EU
ACA
Credit Agricole
NYSE
NKE
Nike
EU
BN
Danone
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés